Wed, April 30, 2025
[ Wed, Apr 30th 2025 ]: BBC
Stacey & Joe: Trying to remember all the family birthdays
Tue, April 29, 2025
[ Tue, Apr 29th 2025 ]: WEAU
Imagine Summit hosted by WIN Technology took place at CVTC
[ Tue, Apr 29th 2025 ]: SciTechDaily
New Molecule Supercharges Perovskite Solar Cells for Higher Efficiency and Stability
[ Tue, Apr 29th 2025 ]: WTVY
Carver School for Math, Science and Technology receives national distinction
[ Tue, Apr 29th 2025 ]: Forbes
How The Tech Brain Drain Is Benefiting China And The EU
[ Tue, Apr 29th 2025 ]: STAT
STAT readers on the value of medical comedy, the pediatrician shortage, and more
[ Tue, Apr 29th 2025 ]: TechCrunch
The TechCrunch Cyber Glossary | TechCrunch
[ Tue, Apr 29th 2025 ]: CNN
Amazon launches Project Kuiper satellites designed to compete with Elon Musk's SpaceX | CNN
[ Tue, Apr 29th 2025 ]: WGAL
University responds to student petition over counseling services
[ Tue, Apr 29th 2025 ]: ABC
HHS firings, questioning safety of vaccines: How .. e Trump administration may be 'attacking' science
[ Tue, Apr 29th 2025 ]: BBC
The time Madonna showed up at Self Esteem's gig
[ Tue, Apr 29th 2025 ]: ThePrint
Charaka Samhita to Arthashastra, new NCERT Class .. ience book highlights India's scientific heritage
Mon, April 28, 2025
[ Mon, Apr 28th 2025 ]: Today
Do ice baths have benefits? What the science shows
[ Mon, Apr 28th 2025 ]: Impacts
Top Emerging Sectors for Actuary Jobs in 2025
[ Mon, Apr 28th 2025 ]: news4sanantonio
Online content moderation: 'An imperfect science'
[ Mon, Apr 28th 2025 ]: BBC
When you lose Florida on the world map
[ Mon, Apr 28th 2025 ]: STAT
Uniqure gets FDA OK to seek accelerated approval
[ Mon, Apr 28th 2025 ]: ThePrint
'Forensic and Technology in New Criminal Laws' workshop held in Goa
[ Mon, Apr 28th 2025 ]: Monitor
Mbale SS to launch Shs4b Science hub
[ Mon, Apr 28th 2025 ]: Forbes
Humanoid Robots: A New Frontier In Technology Investments
Sun, April 27, 2025
[ Sun, Apr 27th 2025 ]: CNN
Fareed's take: Trump's assault on science is dest .. ying a pillar of American strength | CNN Politics
[ Sun, Apr 27th 2025 ]: Forbes
K18 And The Science Of Trust: How One Haircare Brand Reframed Beauty Through Biotechnology
[ Sun, Apr 27th 2025 ]: NDTV
Blogs: K Kasturirangan's Contribution To Space Science And Nation Building - A Legacy
[ Sun, Apr 27th 2025 ]: Daily
ISRO, SCTIMST sign MOU to boost Space Medicine Research
[ Sun, Apr 27th 2025 ]: BBC
A perfect Sunday at Pickle Cottage
[ Sun, Apr 27th 2025 ]: KXAN
Understanding the science and power of a supercell
Sat, April 26, 2025
[ Sat, Apr 26th 2025 ]: BBC
Aid worker caught in Ukraine hotel missile strike
[ Sat, Apr 26th 2025 ]: CNN
Trump's first-term pick to run the National Science Foundation quits: 'I have done all I can'
[ Sat, Apr 26th 2025 ]: Daily
Indian Scientists Develop Eco-Friendly Cholesterol Detection Device
Fri, April 25, 2025
[ Fri, Apr 25th 2025 ]: WSOC
'Science will catch up': 1981 cold case still haunts retired CMPD detective
[ Fri, Apr 25th 2025 ]: WWD
Blake Lively, Serena Williams and a Nobel Science Winner: Inside the Time 100 Gala Scene
[ Fri, Apr 25th 2025 ]: Today
100 science trivia questions that will give your brain a workout
[ Fri, Apr 25th 2025 ]: Investopedia
Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue
[ Fri, Apr 25th 2025 ]: ThePrint
Kasturirangan's contributions to space science will be remembered always: Kerala Guv
[ Fri, Apr 25th 2025 ]: BBC
Andrew Flintoff recounts Top Gear crash
[ Fri, Apr 25th 2025 ]: CNN
5 things to know for April 25: Trump, India-Pakis .. Jewish surveys, National Science Foundation | CNN
[ Fri, Apr 25th 2025 ]: WRDW
Aiken County Career and Technology Center hosts Bio Bash
[ Fri, Apr 25th 2025 ]: SciTechDaily
How Lasers Recreated a Cosmic Shockwave - And Solved a 40-Year Mystery of Particle Acceleration
Thu, April 24, 2025
[ Thu, Apr 24th 2025 ]: Politico
Trump-appointed National Science Foundation leader resigns
[ Thu, Apr 24th 2025 ]: CNN
'Extraordinary' fossil reveals the oldest ant species known to science | CNN
[ Thu, Apr 24th 2025 ]: MassLive
Musk budget chainsaw dulls science days for third .. raders in Springfield (The Republican Editorials)
[ Thu, Apr 24th 2025 ]: Newsweek
Yankees $8.6 Million All-Star Closer Compared to 'Failed Science Project'
[ Thu, Apr 24th 2025 ]: Daily
Indigenously developed HPV test kits launched for Cervical Cancer screening
[ Thu, Apr 24th 2025 ]: HousingWire
Consolidated Analytics changes appraisals from "Art" to "Science"
[ Thu, Apr 24th 2025 ]: BBC
Would you travel the world with your ex?
Wed, April 23, 2025
[ Wed, Apr 23rd 2025 ]: CNN
The tech helping to biohack our way to longevity | CNN
[ Wed, Apr 23rd 2025 ]: Zawya
The Ministry of Education and Higher Education an .. the inclusion of new STEM/TVET teaching programs
[ Wed, Apr 23rd 2025 ]: BBC
Vatican staff queue to see Pope in open coffin

Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. ping-covid-19-cancer-drug-sales-hit-revenue.html
  Print publication without navigation Published in Science and Technology on by Investopedia
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains editorial commentary or bias from the source
Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined.
Gilead Sciences experienced a significant drop in its stock price, falling over 10% after reporting a 4% year-over-year revenue decline to $6.6 billion in the third quarter, primarily due to decreased sales of its COVID-19 treatment, Veklury, and cancer drug, Yescarta. The company's oncology division saw a 26% revenue drop, attributed to reduced demand for Yescarta and challenges in the launch of Trodelvy. Despite these setbacks, Gilead's HIV treatment segment showed growth, with a 4% increase in sales, driven by demand for Biktarvy. The company also revised its full-year revenue guidance downwards, now expecting between $26.7 billion and $26.9 billion, reflecting the ongoing impact of lower Veklury sales. Additionally, Gilead announced a $3 billion share repurchase program to return value to shareholders amidst these challenges.

Read the Full Investopedia Article at:
[ https://www.investopedia.com/gilead-sciences-stock-falls-as-slumping-covid-19-cancer-drug-sales-hit-revenue-11721926 ]